The EU Commission launches sector inquiry into the pharmaceutical sector

"Commission launches sector inquiry into pharmaceuticals"* On 15 January 2008, the Commission initiated an inquiry into the pharmaceutical sector. As a first step, the Commission undertook unannounced inspections at the premises of a number of pharmaceutical companies in the EU. It was supported by officials of the national competition authorities. The Commission inspected producers of innovative medicines as well as producers of generic medicines [1]. This was the first time the Commission had launched a sector inquiry with unannounced inspections [2]. This article will briefly explain what a sector inquiry is, why the Commission has decided to open such an inquiry in the area of pharmaceuticals, what the scope of the inquiry is and how it will be conducted. I. What is a sector

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Bertus Van Barlingen, Monica Alfaro-Murcia, Philipp Gasparon, Sune Chabert Larsen, Harald Mische, The EU Commission launches sector inquiry into the pharmaceutical sector, 15 January 2008, e-Competitions January 2008, Art. N° 35280

Visites 770

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues